| #34 |
Ian D. Robertson |
University Of Illinois |
1 |
| #34 |
Jeffrey R. Finkelmeier |
Braemar Manufacturing |
1 |
| #34 |
James John Kolcun |
— |
1 |
| #34 |
Anthony F DiCastelnuovo |
— |
1 |
| #34 |
Nicholas D. Adams |
Cytokinetics |
1 |
| #34 |
Helai MOHAMMAD |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Eric P. Wasserman |
Rohm And Haas |
1 |
| #34 |
William Duffield |
Institute For Musculoskeletal Science And Education |
1 |
| #34 |
Katherine L. Widdowson |
Smithkline Beecham Limited |
1 |
| #34 |
Taraka Sai Pavan Grandhi |
Arizona Board Of Regents For And On Behalf Of Arizona State University |
1 |
| #34 |
Jason W. DODSON |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Gina M Andaloro |
— |
1 |
| #34 |
Joseph J. Romano |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Sarah Gerhart |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Ryan G. Kruger |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Margaret Fedgchin |
Johnson & Johnson |
1 |
| #34 |
William P. McDonough |
Depuy Synthes Products |
1 |
| #34 |
Jenny Laraio |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Jessica D. Drazba |
Dow Global Technologies |
1 |
| #34 |
Arthur Balzereit |
— |
1 |
| #34 |
Jonathan M. Ghergurovich |
Princeton University |
1 |
| #34 |
James Raymond Brown |
Smithkline Beecham Limited |
1 |
| #34 |
Joseph V. Bondi |
Merck |
1 |
| #34 |
Douglas E. Fuerst |
Codexis |
1 |
| #34 |
María Lourdes Rueda Benede |
Cancer Research Technology Limited |
1 |
| #34 |
Saji Pillai |
Stein Seal |
1 |
| #34 |
Mathew Gordon |
Institute For Musculoskeletal Science And Education |
1 |
| #34 |
Sreevani Komerisheety |
Rovi Guides |
1 |
| #34 |
Zahid Asif |
Dow Global Technologies |
1 |
| #34 |
Neville A. Black |
Comcast |
1 |
| #34 |
Yiqian Lian |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Karen Anderson Evans |
Cancer Research Technology Limited |
1 |
| #34 |
Andy FEDORIW |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Himal Ray |
Rohm And Haas |
1 |
| #34 |
Niyant Shah |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Olena I. Barbash |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Rachel Apfelbaum |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #34 |
George C. Morton |
Bristol-Myers Squibb |
1 |
| #34 |
Marc Chevrier |
Johnson & Johnson |
1 |
| #34 |
Stuart Paul Romeril |
Glaxosmithkline |
1 |
| #34 |
Ping Zhang |
Glaxosmithkline Intellectual Property Development Limited |
1 |
| #34 |
Gregg A. Charlton |
Interdigital Patent Holdings |
1 |
| #34 |
William Henry Miller |
Smithkline Beecham Limited |
1 |
| #34 |
Kinjalbahen Joshi |
Rohm And Haas |
1 |
| #34 |
Ruth Tal-Singer |
Glaxosmithkline Biologicals Sa |
1 |
| #34 |
Gregg Barcan |
Glaxosmithkline Intellectual Property (No. 4) Limited |
1 |
| #34 |
John Michael Kolcun |
— |
1 |
| #34 |
Gunter E. Moeller |
Arkema |
1 |
| #34 |
Brittney Gurda |
University Of North Carolina At Chapel Hill |
1 |
| #34 |
Martha J. Kelly |
Rohm And Haas |
1 |